CD3- PREVENTION OF ADVERSE EFFECTS CAUSED BY CD3 SPECIFIC BINDING DOMAINS

摘要

The present invention relates to glucocorticoids (GC) for use in the amelioration, treatment or prevention of neurological / psychiatric adverse events caused by the CD3 binding domain. Also disclosed are kits comprising instructions for indicating that the GC, CD3 binding domain and GC are intended for use in the treatment, amelioration and / or prevention of neurological adverse events caused by the CD3 binding domain.